These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup. Haferkamp A, Bastian PJ, Jakobi H, Pritsch M, Pfitzenmaier J, Albers P, Hallscheidt P, Müller SC, Hohenfellner M. J Urol; 2007 May; 177(5):1703-8. PubMed ID: 17437789 [Abstract] [Full Text] [Related]
7. Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma: a stratification tool for prospective clinical trials. Leibovich BC, Han KR, Bui MH, Pantuck AJ, Dorey FJ, Figlin RA, Belldegrun A. Cancer; 2003 Dec 15; 98(12):2566-75. PubMed ID: 14669275 [Abstract] [Full Text] [Related]
17. Expanding the indications for surgery and adjuvant interleukin-2-based immunotherapy in patients with advanced renal cell carcinoma. Belldegrun A, Shvarts O, Figlin RA. Cancer J Sci Am; 2000 Feb 15; 6 Suppl 1():S88-92. PubMed ID: 10685666 [Abstract] [Full Text] [Related]
19. [Transabdominal radical nephrectomy for renal cell carcinoma: an experience on 155 patients]. Chen XF, Zhou FJ, Han H, Qin ZK, Liu ZW, Yu SL, Li YH, Wang H, Hou GL. Ai Zheng; 2007 May 15; 26(5):528-32. PubMed ID: 17672946 [Abstract] [Full Text] [Related]